Liver-adipose tissue crosstalk in non-alcoholic fatty liver disease: The emerging role of remnant cholesterol
- 27 June 2023
- journal article
- letter
- Published by Elsevier in Journal of Hepatology
- Vol. 80 (3) , e111-e112
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Remnant Cholesterol Independently Predicts the Development of Nonalcoholic Fatty Liver DiseaseThe Journal of Clinical Endocrinology & Metabolism, 2023
- An adipocentric perspective on the development and progression of non-alcoholic fatty liver diseaseJournal of Hepatology, 2023
- Remnant Cholesterol Predicts Long-term Mortality of Patients With Metabolic Dysfunction–associated Fatty Liver DiseaseThe Journal of Clinical Endocrinology & Metabolism, 2022
- Lipid Transport in Brown Adipocyte ThermogenesisFrontiers in Physiology, 2021
- Remnant Lipoprotein Cholesterol as a Factor Related to Adult Fatty Liver DiseaseThe Journal of Clinical Endocrinology & Metabolism, 2021
- Remnant Cholesterol, Not LDL Cholesterol, Is Associated With Incident Cardiovascular DiseaseJACC, 2020
- Brown fat activation reduces hypercholesterolaemia and protects from atherosclerosis developmentNature Communications, 2015
- Brown adipose tissue activity controls triglyceride clearanceNature Medicine, 2011